Company lists · Data refreshed September 2026
Top 9 Rare disease drug manufacturers based in Australia
RevenueBase identified 27 rare disease drug manufacturers headquartered in Australia as of September 2026 and tracks 236 professional contacts across them, including 43 with verified work emails. Melbourne is the largest hub.
This list covers rare disease drug manufacturers headquartered in Australia, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, its RevenueBase Smart Search rating, and when it was last checked. Data refreshed September 17, 2026.
Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase Smart Search, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.
The 9 largest rare disease drug manufacturers based in Australia
Ranked by team size| # | Company | Contacts | |||
|---|---|---|---|---|---|
| 1 | 17 contacts → | ||||
Partial evidence “PharmSky Research is a pharmaceutical contract research and drug development organisation in Melbourne, Australia.” Source: RevenueBase Database · checked Sep 17, 2026Thanks. The Data Team will review it. | |||||
| 2 | 11 contacts → | ||||
Indirect evidence “Distribution of specialised medical products and pharmaceuticals” Source: RevenueBase Database · checked Sep 17, 2026Thanks. The Data Team will review it. | |||||
| 3 | 10 contacts → | ||||
Partial evidence “InterPharma Pty Ltd, a wholly owned subsidiary of EVER Pharma is a fully integrated specialty pharmaceuticals company focused on the research, development, manufacture, and…” Source: RevenueBase Database · checked Sep 17, 2026Thanks. The Data Team will review it. | |||||
| 4 | 6 contacts → | ||||
Indirect evidence “Reliis has a clear vision of creating innovative solutions by leveraging safe and effective medicines to address unmet clinical needs, with significant commercial value.” Source: RevenueBase Database · checked Sep 17, 2026Thanks. The Data Team will review it. | |||||
| 5 | 6 contacts → | ||||
Indirect evidence “At MLS Bio, we are developing first-in-class small-molecule therapeutics targeting tetraspanins, a novel and underexplored class of cell-surface proteins that play a critical…” Source: RevenueBase Database · checked Sep 17, 2026Thanks. The Data Team will review it. | |||||
| 6 | 4 contacts → | ||||
Strong evidence “Sobi is a specialised international biopharmaceutical company transforming the lives of people with rare diseases.” Source: RevenueBase Database · checked Sep 17, 2026Thanks. The Data Team will review it. | |||||
| 7 | 2 contacts → | ||||
Indirect evidence “Adjutor Healthcare Group are specialists in end-to-end development and commercialisation of medicines and medical devices.” Source: RevenueBase Database · checked Sep 17, 2026Thanks. The Data Team will review it. | |||||
| 8 | 2 contacts → | ||||
Indirect evidence “The company was founded to serve unmet medical needs and to provide niche solutions.” Source: RevenueBase Database · checked Sep 17, 2026Thanks. The Data Team will review it. | |||||
| 9 | 1 contacts → | ||||
Indirect evidence “JEM is an privately owned Australian pharmaceutical company committed to making a difference to people’s lives by providing highly specialised products to treat serious or…” Source: RevenueBase Database · checked Sep 17, 2026Thanks. The Data Team will review it. | |||||
RevenueBase Smart Search
RevenueBase Smart Search assesses information from a company’s LinkedIn profile, information supplied directly by the company, its website, and other publicly available sources. It uses that information to rate how closely the company relates to this list’s category: rare disease drug manufacturers. Every row carries its rating and the description the rating was read from, so each one can be checked rather than taken on trust.
- Strong evidence
- The company's own public description of its business names rare disease drug manufacturers.
- Partial evidence
- Its own public description names part of rare disease drug manufacturers, so it works in or next to the category without describing itself that way.
- Indirect evidence
- The description shown does not name rare disease drug manufacturers. The match rests on the rest of the company's public profile rather than the one sentence quoted here, so this is the rating to check first.
RevenueBase Smart Search is how these lists are built: RevenueBase's data engine and AI assemble the companies that match a category defined in a user's own words, so a list can be about what companies actually do rather than about whichever industry code they were filed under.
Showing 9 of 27 rare disease drug manufacturers based in Australia
See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 43 reachable decision-makers.
Free signup · no credit card
Rare disease drug manufacturers based in Australia at a glance
As of Sep 17, 2026Companies by employee count
Email recency for this list is measured worldwide rather than for Australia, so it is reported there. Company counts and contact totals on this page are exact for Australia, over 27 companies.
How this list was built
Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among rare disease drug manufacturers, so some rows will be adjacent to the category rather than pure plays. The description and RevenueBase Smart Search rating on every row are there so you can check each match yourself.
- Source
- The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase Smart Search, the natural-language company search available to every RevenueBase user.
- What qualifies
- Companies headquartered in Australia whose own description of what they do matches “rare disease drug manufacturers”. Matching reads each company's description, not its industry code or its name.
- RevenueBase Smart Search
- RevenueBase Smart Search is how this list is assembled and how each row is rated. RevenueBase's data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to a category defined in a user's own words. Each row is rated strong evidence (its own description names rare disease drug manufacturers), partial evidence (it names part of the category) or indirect evidence (the description shown names none of it and the match rests on the rest of the company's profile). The description supporting each rating is quoted on the row.
- What we exclude
- Companies whose own description does not clearly place them among rare disease drug manufacturers, and records with no verified work email. Companies headquartered outside Australia are excluded even when they keep an office there.
- Match quality
- In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and its RevenueBase Smart Search rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
- Ranking
- Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
- Verification
- Every listed company carries at least one verified work email, 43 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
- Refresh
- This page's figures were pulled from the company graph on September 17, 2026. Lists refresh periodically as the graph is re-checked.
- Corrections
- Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.
Frequently asked
What is RevenueBase Smart Search?
RevenueBase Smart Search is how RevenueBase decides which companies belong on this list and how strongly each one fits. Its data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to the category the list is about. Each row is rated strong evidence when the company's own description names rare disease drug manufacturers, partial evidence when it names part of the category, and indirect evidence when the description shown names none of it and the match rests on the rest of the company's profile.
How many rare disease drug manufacturers are there based in Australia?
RevenueBase identified 27 rare disease drug manufacturers headquartered in Australia as of September 2026, matched on each company's own description of what it does rather than its industry code.
What is the largest company on this list?
Pharmsky Research, headquartered in Dandenong South, tops this list with the largest team on record.
Which city has the most rare disease drug manufacturers?
Melbourne leads with 8 headquartered companies, followed by Adelaide (2) and Norwest (2).
How do I get contact information for these companies?
A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 43 verified decision-maker contacts tracked across these 27 companies.
How current is this list?
The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 17, 2026.
Ready to reach these companies? Verified emails and direct dials for all 27 rare disease drug manufacturers based in Australia. Start with a free account, no credit card.
Download this list →Related lists
Rare disease drug manufacturers by geography
- Rare disease drug manufacturers based in Ahmedabad, India
- Rare disease drug manufacturers based in Hyderabad, India
- Rare disease drug manufacturers based in Mumbai, India
- Rare disease drug manufacturers based in Argentina
- Rare disease drug manufacturers based in Brazil
- Rare disease drug manufacturers based in Canada
- Rare disease drug manufacturers based in China
- Rare disease drug manufacturers based in France
- Rare disease drug manufacturers based in Germany
- Rare disease drug manufacturers based in India
- Rare disease drug manufacturers based in Italy
- Rare disease drug manufacturers based in Japan
Browse the directory
Browse: Companies home · All Australia lists · All Rare disease drug manufacturers lists · New lists
About this data
RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase Smart Search, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.
More company lists
- All company lists
- Lists by location
- Lists A-Z
- New lists
- Rare disease drug manufacturers based in Ahmedabad, India
- Rare disease drug manufacturers based in Hyderabad, India
- Rare disease drug manufacturers based in Mumbai, India
- Rare disease drug manufacturers based in Argentina
- Rare disease drug manufacturers based in Brazil
- Rare disease drug manufacturers based in Canada